Back
Replimune Group Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
45
REPL
Replimune Group
Last Price:
12.47
Seasonality Move:
-9.23%
Sell
39
NBY
NovaBay Pharmaceuticals
Last Price:
0.70
Seasonality Move:
-7.72%
Sell
45
Replimune Group (REPL)
is a Sell
Is Replimune Group a Buy, Sell or Hold?
- The current Replimune Group [REPL] share price is $12.44. The Score for REPL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- REPL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.69. The Score for NBY is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REPL Stock Price Chart
What is Replimune Group's stock price today?
-
The Replimune Group share price today is $12.44
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REPL is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.69
The current trend is relatively stagnant and NBY is experiencing slight buying pressure.
REPL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.3 | Buy |
Relative Strength Index (14 RSI): | 58.71 | Buy |
Chaikin Money Flow: | -13457 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.26 - 12.24) | Buy |
Bollinger Bands (100): | (9.34 - 11.6) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 53.8 | Buy |
Chaikin Money Flow: | 74506 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.6 - 0.72) | Buy |
Bollinger Bands (100): | (0.3 - 1.7) | Sell |
REPL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.14 | Buy |
20-day SMA: | 11.81 | Buy |
50-day SMA: | 11.33 | Buy |
200-day SMA: | 8.92 | Buy |
8-day EMA: | 12.2 | Buy |
20-day EMA: | 11.92 | Buy |
50-day EMA: | 11.34 | Buy |
200-day EMA: | 10.49 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.73 | Sell |
20-day SMA: | 0.65 | Buy |
50-day SMA: | 0.61 | Buy |
200-day SMA: | 2.57 | Sell |
8-day EMA: | 0.7 | Sell |
20-day EMA: | 0.68 | Buy |
50-day EMA: | 0.74 | Sell |
200-day EMA: | 6.08 | Sell |
Replimune Group Earnings Growth & REPL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $0.18 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Replimune Group Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |